We are delighted to announce that Klas Therapeutics and our CEO, Prof. Bridgeen Callan, are among the 40 winners of the Women TechEU award. The program received over 800 applications from a range of deep tech female lead companies from across Europe.
This EU funded program not only provides a 75K€ monetary award, but also 6 months of personalised tailored services to assist klas in addressing our next challenges on the road to commercialisation.
We are excited to be part of this program and look forward to working with the Women TechEU team and the other award winners.
